These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3883589)
1. Successful cadaver kidney transplantation in patients highly sensitized by blood transfusions. Unimportance of the most reactive serum in the pretransplant crossmatch. Norman DJ; Barry JM; Wetzsteon PJ Transplantation; 1985 Mar; 39(3):253-5. PubMed ID: 3883589 [TBL] [Abstract][Full Text] [Related]
2. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614 [TBL] [Abstract][Full Text] [Related]
5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
6. The relationship between flow cytometer crossmatch results and subsequent rejection episodes in cadaver renal allograft recipients. Lazda VA; Pollak R; Mozes MF; Jonasson O Transplantation; 1988 Mar; 45(3):562-5. PubMed ID: 3279580 [TBL] [Abstract][Full Text] [Related]
7. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Bingaman AW; Murphey CL; Palma-Vargas J; Wright F Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435 [TBL] [Abstract][Full Text] [Related]
8. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Tellis VA; Matas AJ; Senitzer D; Louis P; Glicklich D; Soberman R; Veith FJ Transplantation; 1989 Jan; 47(1):127-9. PubMed ID: 2643222 [TBL] [Abstract][Full Text] [Related]
9. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682 [TBL] [Abstract][Full Text] [Related]
10. Improved allograft survival in nonidentical living related donor transplants using donor-specific blood transfusions. Mendez R; Mendez RG; Iwaki YI; Kinukawa T; Bogaard TP; Self BA; Terasaki PI J Urol; 1985 Mar; 133(3):383-5. PubMed ID: 3973987 [TBL] [Abstract][Full Text] [Related]
11. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Lorenz M; Regele H; Schillinger M; Kletzmayr J; Haidbauer B; Derfler K; Druml W; Böhmig GA Transplantation; 2005 Mar; 79(6):696-701. PubMed ID: 15785376 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100 [TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation across a positive crossmatch: a single-center experience. Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017 [TBL] [Abstract][Full Text] [Related]
14. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin. Yuan XP; Wang CX; Gao W; Fu Q; He XS Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369 [TBL] [Abstract][Full Text] [Related]
15. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report. Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279 [TBL] [Abstract][Full Text] [Related]
16. Crossmatching with B and T cells and flow cytometry. Iwaki Y; Lau M; Cook DJ; Takemoto S; Terasaki PI Clin Transpl; 1986; ():277-84. PubMed ID: 3154417 [TBL] [Abstract][Full Text] [Related]
17. An apparent paradoxical effect of pretransplant blood transfusions. Its association with decreased anti-HLA antibody formation following unsuccessful renal transplantation. Lobo PI Transplantation; 1984 Jun; 37(6):562-4. PubMed ID: 6375015 [TBL] [Abstract][Full Text] [Related]
18. Prospective trial of a predictive algorithm to transplant cadaver kidneys into highly sensitized patients. Thompson JS; Thacker L; Byrne J Transplantation; 2002 Apr; 73(8):1274-80. PubMed ID: 11981421 [TBL] [Abstract][Full Text] [Related]
19. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients. Matignon M; Tagnaouti M; Audard V; Dahan K; Lang P; Grimbert P Transplant Proc; 2007 Oct; 39(8):2565-7. PubMed ID: 17954175 [TBL] [Abstract][Full Text] [Related]
20. Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Noreen HJ; McKinley DM; Gillingham KJ; Matas AJ; Segall M Transplantation; 2003 Feb; 75(4):501-5. PubMed ID: 12605118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]